AstraZeneca says COVID-19 drug neutralises Omicron sub-variants in study - CNA

3/21/2022 12:00:00 AM3 years 1 month ago

AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study. Data from the study by…

AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-var… [+1369 chars]

full article...